Novotech News

  1. Novotech Appoints Commercial And Clinical Life Sciences Specialist To Head Up Global Drug Development Consulting Team 5/10/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).

  2. Novotech Publishes Research Report On Acute Myeloid Leukaemia Clinical Trial Landscape For Clinical Stage Biotechs 4/15/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia - Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid Leukemia (AML) research.

  3. Novotech Publishes Analyst Report On Cystic Fibrosis Clinical Trial Landscape To Inform Biotech Research Planning  4/11/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis - Global Clinical Trial Landscape.

  4. Novotech Publishes Duchenne Muscular Dystrophy Landscape Report To Support Biotech Research Planning  3/15/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape.

  5. Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends And Opportunities In Targeted Therapies 3/14/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an insightful whitepaper, Precision Oncology - Global Clinical Trial Landscape, providing the latest research insights for cancer treatments.

  6. Novotech Publishes Candidiasis And Rheumatoid Arthritis Clinical Trial Landscape Reports To Support Biotech Research Planning 2/19/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today two industry leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes.

  7. New Novotech Report Finds 1,000 HIV Clinical Trials Globally 1/10/2024

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.

  8. Early-Stage Biotech Investments Were Down 40% In 2023: Novotech Whitepaper 1/9/2024

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the Navigating the Biotech Landscape whitepaper examining the significant financial shifts that affected the biotech industry in 2023.

  9. Novotech Executive Team At J.P. Morgan Healthcare Conference: Global CRO Designed For Biotechs Across 25 Regions 1/9/2024

    Novotech, a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.

  10. New Novotech Report On Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018 12/15/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Metastatic Breast Cancer.